K. Lysko

Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.

Hung‐Yuan Cheng, T. Yue, P. J. McKenna, 1992, The Journal of pharmacology and experimental therapeutics.

SB 211475, a metabolite of carvedilol, a novel antihypertensive agent, is a potent antioxidant.

T. Yue, P. J. McKenna, G. Feuerstein, 1994, European journal of pharmacology.

Protein involvement in structural transition of erythrocyte ghosts. Use of thermal gel analysis to detect protein aggregation.

J. Brandts, J. Snow, R. Taverna, 1981, Biochemistry.

Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions.

G. Feuerstein, R. Mason, P. Lysko, 1998, Biochemical pharmacology.

Calorimetric studies of the structural transitions of the human erythrocyte membrane. The involvement of spectrin in the A transition.

L. Erickson, J. Brandts, R. Taverna, 1977, Biochemistry.

Genetic and molecular principles for the selection of Pseudomonas and Staphylococcus therapeutic bacteriophages

E. Kulikov, K. Miroshnikov, K. Lysko, 2014, Applied Biochemistry and Microbiology.

Calorimetric studies of the structural transitions of the human erythrocyte membrane. Studies of the B and C transitions.

J. Brandts, R. Taverna, E. Sadasivan, 1978, Biochimica et biophysica acta.

Neuroprotective Effects of Carvedilol, a New Antihypertensive Agent, in Cultured Rat Cerebellar Neurons and in Gerbil Global Brain Ischemia

T. Yue, G. Feuerstein, J. Gu, 1992, Stroke.

Neuroprotective effects of carvedilol, a new antihypertensive, at the N-methyl-d-aspartate receptor

G. Feuerstein, P. Lysko, C. Webb, 1992, Neuroscience Letters.